Yazan F Madanat (Yazan Madanat)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 25

Top Topics

Acute Myeloid Leukemia

Peritoneal Dialysis

Allogeneic Hematopoietic Stem Cell Transplantation

Newly Diagnosed

Top Venues

Leukemia & lymphoma

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma (2024)
Courtney D D DiNardo, Gail J Roboz, Justin M Watts, Yazan F Madanat, Gabrielle T Prince, Praneeth Baratam, Stéphane de Botton, Anthony S Stein, James M Foran, Martha L Arellano, David A Sallman, Mohammad Hossain, Dylan M Marchione, Xiaofei Bai, Prapti A Patel, Stephanie M Kapsalis, Guillermo Garcia-Manero, Amir T Fathi
Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome. Blood advances (2024)
Courtney D D DiNardo, Gail J Roboz, Justin M Watts, Yazan F Madanat, Gabrielle T Prince, Praneeth Baratam, Stéphane de Botton, Anthony S Stein, James M Foran, Martha L Arellano, David A Sallman, Mohammad Hossain, Dylan M Marchione, Xiaofei Bai, Prapti A Patel, Stephanie M Kapsalis, Guillermo Garcia-Manero, Amir T Fathi
Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome. Blood advances (2024)
Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma (2024)
Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma 65 (5) (2024)
Fieke W Hoff, William Blum, Ying Huang, Rina Li Welkie, Ronan Swords, Jennifer Dunlap, Eytan M Stein, Tara L Lin, Kellie J Archer, Prapti A Patel, Robert H Collins, Maria R Baer, Vu H Duong, Martha L Arellano, Wendy Stock, Olatoyosi Odenike, Robert L Redner, Tibor J Kovacsovics, Michael W Deininger, Joshua F Zeidner, Rebecca L Olin, Catherine C Smith, James M Foran, Gary J Schiller, Emily Curran, Kristin L Koenig, Nyla A Heerema, Timothy L Chen, Molly Martycz, Mona Stefanos, Leonard Rosenberg, Brian J Druker, Ross L Levine, Amy Burd, Ashley O Yocum, Uma Borate, Alice S Mims, John C Byrd, Yazan F Madanat
Beat-AML 2024 ELN-Refined Risk Stratification for Older Adults with Newly Diagnosed AML Given Lower-Intensity Therapy. Blood advances (2024)
Zhuoer Xie, Rami S Komrokji, Najla Al-Ali, Alexandra Regelson, Susan Geyer, Anand Ashwin Patel, Caner Saygin, Amer M Zeidan, Jan Philipp Bewersdorf, Lourdes M Mendez, Ashwin Kishtagari, Joshua F Zeidner, Catherine C Coombs, Yazan F Madanat, Stephen S Chung, Talha Badar, James M Foran, Pinkal Desai, Charlton Tsai, Elizabeth A Griffiths, Monzr M Al Malki, Idoroenyi Amanam, Catherine E Lai, H Joachim Deeg, Lionel Ades, Cecilia Arana-Yi, Afaf E G Osman, Shira Naomi Dinner, Yasmin M Abaza, Justin Taylor, Namrata S Chandhok, Deborah Soong, Andrew M Brunner, Hetty E Carraway, Abhay Singh, Chiara Elena, Jacqueline Ferrari, Anna Galli, Sara Pozzi, Eric Padron, Mirinal S Patnaik, Luca Malcovati, Michael R Savona, Aref A Al-Kali
Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence. Blood (2024)
Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma 65 (5) (2024)
Tariq Kewan, Arda Durmaz, Waled Bahaj, Carmelo Gurnari, Laila Terkawi, Hussein Awada, Olisaemeka D Ogbue, Ramsha Ahmed, Simona Pagliuca, Hassan Awada, Yasuo Kubota, Minako Mori, Ben Ponvilawan, Bayan Al-Share, Bhumika J Patel, Hetty E Carraway, Jacob Scott, Suresh K Balasubramanian, Taha Bat, Yazan F Madanat, Mikkael A Sekeres, Torsten Haferlach, Valeria Visconte, Jaroslaw P Maciejewski
Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia. Nature communications 15 (1) (2024)
Courtney D D DiNardo, Gail J Roboz, Justin M Watts, Yazan F Madanat, Gabrielle T Prince, Praneeth Baratam, Stéphane de Botton, Anthony Stein, James M Foran, Martha L Arellano, David A Sallman, Mohammad Hossain, Dylan M Marchione, Xiaofei Bai, Prapti A Patel, Stephanie M Kapsalis, Guillermo Garcia-Manero, Amir T Fathi
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome. Blood advances 8 (15) (2024)
Courtney D D DiNardo, Gail J Roboz, Justin M Watts, Yazan F Madanat, Gabrielle T Prince, Praneeth Baratam, Stéphane de Botton, Anthony Stein, James M Foran, Martha L Arellano, David A Sallman, Mohammad Hossain, Dylan M Marchione, Xiaofei Bai, Prapti A Patel, Stephanie M Kapsalis, Guillermo Garcia-Manero, Amir T Fathi
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome. Blood advances 8 (15) (2024)
Tariq Kewan, Arda Durmaz, Waled Bahaj, Carmelo Gurnari, Laila Terkawi, Hussein Awada, Olisaemeka D Ogbue, Ramsha Ahmed, Simona Pagliuca, Hassan Awada, Yasuo Kubota, Minako Mori, Ben Ponvilawan, Bayan Al-Share, Bhumika J Patel, Hetty E Carraway, Jacob Scott, Suresh K Balasubramanian, Taha Bat, Yazan F Madanat, Mikkael A Sekeres, Torsten Haferlach, Valeria Visconte, Jaroslaw P Maciejewski
Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia. Nature communications 15 (1) (2024)
Christina Baroody, Melissa Sandler, Christine Hong, Yazan F Madanat, Stefanie Conley
Evaluation of a decentralized investigational drug service pharmacist in a cancer clinical trial infusion unit. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Mohammad Faizan Zahid, Kelsey Moriarty, Courtney Dryden, Olga K Weinberg, Misha Asif, Ruth Ikpefan, Julia M Anderson, Robert H Collins, Stephen S Chung, Weina Chen, Prapti A Patel, Yazan F Madanat
Identifying patients at risk for hereditary myeloid malignancy syndromes incorporating a novel, self-administered questionnaire to an initial screening platform. European journal of haematology (2023)
Fieke W Hoff, Yazan F Madanat
Molecular Drivers of Myelodysplastic Neoplasms (MDS)-Classification and Prognostic Relevance. Cells 12 (4) (2023)
Fieke W Hoff, Yazan F Madanat
Molecular Drivers of Myelodysplastic Neoplasms (MDS)-Classification and Prognostic Relevance. Cells 12 (4) (2023)
Talha Badar, Yazan F Madanat, Amer M Zeidan
Updates on risk stratification and management of lower-risk myelodysplastic syndromes/neoplasms. Future oncology (London, England) (2023)
Naveen Premnath, Yazan F Madanat
Novel Investigational Agents and Pathways That May Influence the Future Management of Acute Myeloid Leukemia. Cancers 15 (11) (2023)
Fieke W Hoff, Yazan F Madanat
Molecular Drivers of Myelodysplastic Neoplasms (MDS)-Classification and Prognostic Relevance. Cells 12 (4) (2023)
Miguel Dario Cantu, Rashmi Kanagal-Shamana, Sa A Wang, Tapan Mahendra Kadia, Carlos E Bueso-Ramos, Sanjay S Patel, Julia T Geyer, Wayne Tam, Yazan F Madanat, Peng Li, Tracy I George, Meredith M Nichols, Heesun Joyce Rogers, Yen-Chun Liu, Nidhi Aggarwal, Jason H Kurzer, Danielle L V Maracaja, Eric D Hsi, Feras Zaiem, Daniel Babu, Kathryn Foucar, Dorottya Laczko, Adam Bagg, Attilio Orazi, Daniel A Arber, Robert P Hasserjian, Olga K Weinberg
Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. JCO precision oncology 7 (2023)
Naveen Premnath, Yazan F Madanat
Paradigm Shift in the Management of Acute Myeloid Leukemia-Approved Options in 2023. Cancers 15 (11) (2023)
Tariq Kewan, Arda Durmaz, Waled Bahaj, Carmelo Gurnari, Laila Terkawi, Hussein Awada, Olisaemeka D Ogbue, Ramsha Ahmed, Simona Pagliuca, Hassan Awada, Yasuo Kutoba, Minako Mori, Ben Ponvilawan, Bayan Al-Share, Bhumika J Patel, Hetty E Carraway, Jacob Scott, Suresh K Balasubramanian, Taha Bat, Yazan F Madanat, Mikkael A Sekeres, Torsten Haferlach, Valeria Visconte, Jaroslaw P Maciejewski
Molecular patterns identify distinct subclasses of myeloid neoplasia. Nature communications 14 (1) (2023)
Naveen Pemmaraju, Hagop M Kantarjian, Kendra L Sweet, Eunice S Wang, Jayastu Senapati, Nathaniel R Wilson, Marina Y Konopleva, Arthur E Frankel, Vikas K Gupta, Ruben A Mesa, Matthew L Ulrickson, Edward Gorak, Sumeet Bhatia, Tulin Budak-Alpdogan, James R Mason, Maria Teresa García-Romero, Norma C Lopez-Santiago, Gabriela Cesarman-Maus, Pankit Vachhani, Sangmin Lee, Vijaya Raj Bhatt, William Blum, Roland Bruno Walter, Dale Bixby, Ivana Gojo, Madeleine Duvic, Raajit K Rampal, Marcos de Lima, James M Foran, Amir T Fathi, Aric C Hall, Meagan A Jacoby, Jeffrey E Lancet, Gabriel N Mannis, Anthony S Stein, Alice S Mims, David A Rizzieri, Rebecca L Olin, Alexander E Perl, Gary J Schiller, Paul J Shami, Richard M Stone, Stephen A Strickland, Matthew J Wieduwilt, Naval G Daver, Farhad Ravandi, Sumithira Vasu, Monica L Guzman, Gail J Roboz, Joseph D Khoury, Muzaffar H Qazilbash, Leomar Y Ballester, Branko Cuglievan, Yazan F Madanat, Mohamed A Kharfan-Dabaja, Anna B Pawlowska, Justin Taylor, Martin S Tallman, Prajwal Dhakal, Andrew A Lane
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need. Blood (2022)
Olga K Weinberg, Alexa Siddon, Yazan F Madanat, Jeffrey Gagan, Daniel A Arber, Paola Dal Cin, Damodaran Narayanan, Madhu M Ouseph, Jason H Kurzer, Robert P Hasserjian
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML. Blood advances 6 (9) (2022)
Junhua Lyu, Yuxuan Liu, Lihu Gong, Mingyi Chen, Yazan F Madanat, Yuannyu Zhang, Feng Cai, Zhimin Gu, Hui Cao, Pranita Kaphle, Yoon Jung Kim, Fatma N Kalkan, Helen Stephens, Kathryn E Dickerson, Min Ni, Weina Chen, Prapti A Patel, Alice S Mims, Uma Borate, Amy Burd, Sheng F Cai, Cheng Cameron Yin, Mingjian James You, Stephen S Chung, Robert H Collins, Ralph J DeBerardinis, Xin Liu, Jian Xu
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance. Cancer discovery (2022)